Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 23 hours ago

Indications

Doctors use Tolvaptan for hypervolemic or euvolemic hyponatremia. It is also used in autosomal dominant polycystic kidney disease.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Tolvaptan is a selective vasopressin V2-receptor antagonist. Its affinity for the V2-receptor is 29 times greater than for the V1a-receptor. When taken by mouth in doses of 15 to 60 mg, Tolvaptan blocks the effect of vasopressin. This increases the amount of water passing out in the urine, which raises free water clearance (aquaresis) and lowers urine osmolality, and as a result serum sodium concentrations go up. Urinary excretion of sodium and potassium, and plasma potassium concentrations, are not significantly changed.

Pregnancy & Breastfeeding

There is little or no data on the use of Tolvaptan in pregnant women. Animal studies have shown reproductive toxicity, but the possible risk to humans is not known. Tolvaptan is contraindicated during pregnancy, so it must not be used by a pregnant woman. Women who could become pregnant have to use effective contraception for as long as they are on Tolvaptan treatment. It is also not known whether Tolvaptan passes into human milk.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Hypervolemic or euvolemic hyponatremia The usual starting dose of Tolvaptan is 15 mg once daily, and you can take it with or without meals. After at least 24 hours the dose can be increased to 30 mg once daily, and then up to a maximum of 60 mg once daily, as needed to reach the desired level of serum sodium. Don't use it for more than 30 days because of the risk of hepatotoxicity. Autosomal dominant polycystic kidney disease (ADPKD) Start with 60 mg/day in divided doses, given as 45 mg upon wakening and 15 mg 8 hours later. Then titrate according to response and tolerability, leaving at least 7 days between each titration. The first step is 90 mg/day in divided doses (60 mg upon wakening and 30 mg 8 hours later), followed by 120 mg/day in divided doses (90 mg upon wakening and 30 mg 8 hours later). Try to keep urine osmolality below 300 mOsm/kg if possible. If the maximum dose isn't tolerated, a lower dose is reasonable, with the goal of reaching a urine osmolality of 250 to 300 mOsm/kg.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.